Search

Your search keyword '"Warnecke, G."' showing total 1,524 results

Search Constraints

Start Over You searched for: Author "Warnecke, G." Remove constraint Author: "Warnecke, G."
1,524 results on '"Warnecke, G."'

Search Results

156. Cigarette smoke induced pathophysiological changes in the extracellular matrix but not inflammation as early events in fresh human lung tissue

164. Multiple breath washout in pediatric patients after lung transplantation

165. Comparison of IP-10 production induced by ex-vivo stimulation with Respiratory Syncytial Virus (RSV) and the TLR3 agonist Poly I: C in human and non-human primate lung tissues

166. Neue hämodynamische Definition der pulmonalen Hypertonie

174. Cardiac Transplantation in Higher Risk Patients: Is Ex Vivo Heart Perfusion a Safe Preservation Technique? A Two Center Experience

175. Donor T and NK Cells are Derived from the Donor Lung Parenchyme and Represent Tissue-Resident Memory Cells - An Important Feature for Tolerance Development

176. Cardiac Transplantation across Preformed HLA-Antibody Barriers: Results of a Peritransplant Desensitization Protocol

177. Cytokine Expression and Alloreactivity in a Humanized Mouse Transplant Arteriosclerosis Model Reflects Primary Graft Dysfunction in Lung Transplant Recipients

178. Heart-Associated Cytokine and Endothelial Patterns Dominate the Ischemia Reperfusion Response in Recipients of Combined Heart/Lung Transplantation in Comparison to Lung Transplantation

181. Predicted Total Lung Capacity Ratio between Donors and Recipients Does Not Predict Outcomes in Non-Volume Reduced Lung Transplantation

184. Long (>6h) versus Short (<6h) Clinical Normothermic Ex-Vivo Portable Lung Preservation: Post-Hoc Analysis of OCS Lung EXPAND Trial

185. Five-Year Experience with Treatment of Early Donor Specific Anti-HLA Antibodies in Pediatric Lung Transplant Recipients

186. Five-Year Results of an IgA and IgM-Enriched Human Immunoglobulin G-Based Therapy for Early Anti-HLA Donor Specific Antibodies in 158 Lung-Transplanted Patients

187. Effects of Ex Vivo Perfusion and Il-6 Receptor Blockade on Ischemia Reperfusion Injury in Cardiac Transplantation

188. Lung Transplantation from Donation after Circulatory Death Donors Following Portable Ex-Vivo Lung Perfusion: Post-Hoc Analysis of OCS Lung EXPAND Trial

191. Transplant Arteriosclerosis in Humanized Mice Reflects the Presence of Early Donor-Specific Antibodies in Lung Transplant Recipients and Is Controlled by Autologous Regulatory T Cells

192. Five-Year Results of an IgA- and IgM-Enriched Human Immunoglobulin-Based Therapy for Early anti-HLA Donor-Specific Antibodies after Lung Transplantation

194. Ex Vivo Heart Perfusion for Higher Risk Cardiac Transplantations: A Retrospective Analysis from Two German Centers

195. Lung Transplant Recipients with Severe Primary Graft Dysfunction Developed Decreased Transplant Arteriosclerosis in Humanized Mice Models

199. Radiological and Pathological Findings in a Minormismatch Mouse Orthotopic Lung Transplant Model under Immunosuppression.

200. Assessment of long-term cultivated human precision-cut lung slices as an ex vivo system for evaluation of chronic cytotoxicity and functionality

Catalog

Books, media, physical & digital resources